IMM 0.00% 34.0¢ immutep limited

abagovomab fails placebo phase111 trial, page-22

  1. 2,977 Posts.
    lightbulb Created with Sketch. 481
    abdm

    I still question his motives. First he compares chalk with cheese, and then, given Ab's sudden setback, his motivation turns to there being no guarantees for cancer drug hopefuls.

    Well, HELLO, we know that! If guarantees existed, we'd be mortgaging our homes and selling every other asset we own!

    What I take issue with, is posters who exist to spook fellow investors out of sensible, well-researched stocks for the benefit of their own pockets, or some perverted fantasy!

    Preaching to the unconverted is only a good idea if you can back it up with some sensible, hard-won facts. The minute you stray from that you open yourself up to ridicule.

    And that's what people do when their opinions (which they might be entitled to but so often are wrong) change with the weather.

    The one and only drug C-Vac ought be compared to is Provenge.

    That's if you rightly compare the scientific method.

    Otherwise, we might as well begin comparing C-Vac to heroin!

    Because that's how ridiculous some of these comparisons can get.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.000(0.00%)
Mkt cap ! $493.8M
Open High Low Value Volume
34.5¢ 35.0¢ 33.5¢ $724.1K 2.106M

Buyers (Bids)

No. Vol. Price($)
3 60483 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 55452 4
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.